Paper17417627
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H and 2 others. Nat Cell Biol, 2007. Cited by 373 papers, by iCite.
Cite this record
ConductScience Library. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Papers, record 17417627. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17417627
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics32
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle Proteins | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| DNA-Binding Proteins | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Genomic Instability | Major topic |
| Mutation | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Signal Transduction | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Tumor Suppressor Proteins | Major topic |
| ATP-Binding Cassette Transporters | |
| Acid Anhydride Hydrolases | |
| Animals | |
| Ataxia Telangiectasia Mutated Proteins | |
| Cell Cycle | |
| Cells, Cultured | |
| DNA Breaks, Double-Stranded | |
| DNA Repair Enzymes | |
| Fibroblasts | |
| Histones | |
| Humans | |
| MRE11 Homologue Protein | |
| Mice | |
| Mice, Transgenic | |
| Neoplasms | |
| Nuclear Proteins | |
| Phosphorylation | |
| Proto-Oncogene Proteins c-mdm2 | |
| Thymus Gland | |
| Transcription, Genetic | |
| Translocation, Genetic | |
| Ultraviolet Rays |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA77563 | NCI NIH HHS | United States | R01CA077563 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17473858 | p53: a two-faced cancer gene. | https://conductscience.org/library/papers/17473858 |
Source PubMed
Cited by260
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 373 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881229 | Restoration of p53 function via hybrid strontium sulfite nanoparticles modified LNP improves the antitumor efficacy in breast cancers. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/42881229 | PubMed |
| 42533115 | p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway. | Oncogene | 2026 | https://conductscience.org/library/papers/42533115 | PubMed |
| 42352266 | The Enigmatic Tumor Suppressor p53 Biomolecule: Its Role and Prognostic and Predictive Values in Cancer Therapy and Precision Medicine. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352266 | PubMed |
| 41928956 | Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis. | bioRxiv | 2026 | https://conductscience.org/library/papers/41928956 | PubMed |
| 41588183 | Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/41588183 | PubMed |
| 41535270 | A scalable two-step genome editing strategy for generating full-length gene-humanized mice at diverse genomic loci. | Nat Commun | 2026 | https://conductscience.org/library/papers/41535270 | PubMed |
| 41473985 | Multiple ETS family transcription factors bind mutant p53 via distinct interaction regions. | FEBS Lett | 2026 | https://conductscience.org/library/papers/41473985 | PubMed |
| 41468163 | Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41468163 | PubMed |
| 40729726 | A clinical guide to TP53 mutations in myeloid neoplasms. | Blood | 2025 | https://conductscience.org/library/papers/40729726 | PubMed |
| 40699691 | In Silico Design of Quantitative Polymerase Chain Reaction (qPCR) Assay Probes for Prostate Cancer Diagnosis, Prognosis, and Personalised Treatment. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699691 | PubMed |
| 40287981 | Mutant p53 Gain of Function: Why Many See It, Why Some Do Not. | Cancer Discov | 2025 | https://conductscience.org/library/papers/40287981 | PubMed |
| 40210861 | Mutant p53 upregulates HDAC6 to resist ER stress and facilitates Ku70 deacetylation, which prevents its degradation and mitigates DNA damage in colon cancer cells. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40210861 | PubMed |
| 40001547 | The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001547 | PubMed |
| 39944631 | Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/39944631 | PubMed |
| 39845333 | Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation. | Genes Cancer | 2025 | https://conductscience.org/library/papers/39845333 | PubMed |
| 39836208 | [Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate]. | Urologie | 2025 | https://conductscience.org/library/papers/39836208 | PubMed |
| 39644062 | Are TP53 mutations all alike? | Hematology Am Soc Hematol Educ Program | 2024 | https://conductscience.org/library/papers/39644062 | PubMed |
| 39538363 | From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy. | Biomark Res | 2024 | https://conductscience.org/library/papers/39538363 | PubMed |
| 39439908 | Emerging roles of cancer-associated histone mutations in genomic instabilities. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39439908 | PubMed |
| 39421986 | PARP Pioneers: Using BRCA1/2 Mutation-targeted Inhibition to Revolutionize Breast Cancer Treatment. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/39421986 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17417627
GET https://conductscience.org/api/papers/v1/17417627/cited_by?page=2